Literature DB >> 19756621

[Update on immunohistological classification of amyloidoses].

C Röcken1.   

Abstract

The exact classification of amyloid in surgical pathology specimens is complicated by the increasing number of amyloid diseases, with more than 25 different currently known amyloid proteins. Special attention has to be paid to distinguishing hereditary amyloidosis from AL amyloidosis. For this reason we started several years ago to search specifically for hereditary amyloidoses by improving the immunohistochemical classification of amyloid with new antibodies and by applying molecular biology. Since then we have found various cases of systemic and local amyloid diseases in Germany, including, AApoAI-, AFib-, AKer-, ALys- and ATTR-amyloidosis, as well as hitherto unknown amyloidoses. Based on an increasing number of referrals we also collected substantial numbers of cases, which allowed a direct comparison of the prevalences of the various amyloid diseases in organ biopsies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756621     DOI: 10.1007/s00292-009-1183-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  15 in total

1.  [Familial amyloid polyneuropathy of the Portuguese type. Occurrence in a kindred settled in southern Hessen].

Authors:  B Neundörfer; H Kuhn
Journal:  Nervenarzt       Date:  1975-04       Impact factor: 1.214

2.  ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene.

Authors:  Christoph Röcken; Konrad Becker; Marcus Fändrich; Volker Schroeckh; Barbara Stix; Thomas Rath; Thilo Kähne; Jutta Dierkes; Albert Roessner; Franz Werner Albert
Journal:  Hum Mutat       Date:  2006-01       Impact factor: 4.878

3.  Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis.

Authors:  P Babilas; B S Fiebig; C Aslanidis; J Hansen; C Röcken; J Schroeder; G Schmitz; B H F Weber; M Landthaler; T Vogt
Journal:  Br J Dermatol       Date:  2009-05-21       Impact factor: 9.302

4.  Prevalence and origin of amyloid in kidney biopsies.

Authors:  Hanna von Hutten; Michael Mihatsch; Hartmut Lobeck; Birgit Rudolph; Magdalena Eriksson; Christoph Röcken
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

5.  Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin.

Authors:  Barbara Stix; Martina Leber; Peter Bingemer; Christof Gross; Josef Rüschoff; Marcus Fändrich; Daniel F Schorderet; Christian K Vorwerk; Martin Zacharias; Albert Roessner; Christoph Röcken
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

6.  Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee.

Authors: 
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

7.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

Authors:  Helen J Lachmann; David R Booth; Susanne E Booth; Alison Bybee; Janet A Gilbertson; Julian D Gillmore; Mark B Pepys; Philip N Hawkins
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

8.  Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene.

Authors:  Magdalena Eriksson; Stefan Schönland; Saniye Yumlu; Ute Hegenbart; Hanna von Hutten; Zarina Gioeva; Peter Lohse; Janine Büttner; Hartmut Schmidt; Christoph Röcken
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

9.  Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.

Authors:  Saniye Yumlu; Robert Barany; Magdalena Eriksson; Christoph Röcken
Journal:  Hum Pathol       Date:  2009-08-14       Impact factor: 3.466

10.  [Amyloidosis in liver biopsies].

Authors:  Z Gioeva; B Kieninger; C Röcken
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

View more
  1 in total

1.  [Hereditary cardiac amyloidosis with transthyretin mutations. A cause of sudden death ].

Authors:  C Edler; W Saeger; U Orth; C Braun; B Wulff; J Sperhake
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.